Developer docs
API playgroundTry for free, no card

Search company profiles

Shape Memory Medical

Full company profile

uuid0000z1s

Namestring
Shape Memory Medical
Legal namestring
Shape Memory Medical, Inc.
Websiteurl
shapemem.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Shape Memory Medical is a privately held medical device company headquartered in San Jose, California, founded in 2009 to commercialize Shape Memory Polymer (SMP) technology for endovascular embolization. The company's core platform centers on a proprietary bioresorbable polymer that expands and conforms at body temperature, enabling devices that occlude targeted vasculature while integrating embolic material into the vessel. Its commercial product family includes the IMPEDE Embolization Plug, IMPEDE-FX, IMPEDE-FX RapidFill, and the TrelliX Embolic Coil, serving interventional radiologists and vascular surgeons across peripheral and neurovascular embolization indications in more than 40 countries.

The company is expanding its clinical footprint beyond standalone embolization, with the investigational FLAGSHIP False Lumen Embolization System targeting aortic dissection and the AAA-SHAPE Pivotal Trial evaluating sac management adjunct to endovascular aneurysm repair. Regulatory positioning includes the first FDA-cleared SMP-based vascular device, EU MDR Class III certification for the IMPEDE family, PMDA approval in Japan, and recent clearances in Singapore and Malaysia. Distribution is executed through regional partners and a sublicense with a global MedTech leader, supplemented by direct commercial activity in core markets.

Commercial economics follow a B2B medical device model: the company sells Class III implantable devices to hospitals and integrated delivery networks on a per-unit basis, with ASPs typical of vascular embolization products and revenue tied directly to procedure volumes. The company has cumulatively treated more than 3,000 patients as of March 2025, with total disclosed equity funding exceeding $50M, including a $38M Series C led by Earlybird Venture Capital in March 2024 and a $17M follow-on in April 2025.

Short descriptiontext

Shape Memory Medical is a San Jose-based medical device company developing Shape Memory Polymer-based embolization devices (IMPEDE family, TrelliX coils) for interventional radiologists and vascular surgeons across 40+ countries, with active expansion into aortic indications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSanta Clara, United States
HQ citystring
Santa Clara
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
shape memory polymer devices, vascular embolization plugs, neurovascular embolic coils, bioresorbable endovascular devices, peripheral embolization products
Industry3 codes
1Thrombectomy, Embolic Protection & Stroke Intervention Devices
CodeHLAHAFAJPrimaryYes
2Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy)
CodeHLAHAFAEPrimaryNo
3Stroke & Vascular Neurology
CodeHLAKAIAGPrimaryNo
NAICS code1 code
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Endovascular Embolization Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Sale of proprietary shape memory polymer embolization devices to hospitals and healthcare facilities. Revenue generated from one-time device purchases by interventional radiology and vascular surgery departments. Products include IMPEDE Embolization Plug, IMPEDE-FX Embolization Plug, IMPEDE-FX RapidFill, and TrelliX Embolic Coil System.

pulse2.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Impede
Description

IMPEDE Embolization Plug family of embolic plugs for peripheral vascular embolization procedures using shape memory polymer technology.

shapemem.com
+6 more records
Core offering1 text field

Shape Memory Medical develops and commercializes implantable endovascular embolization devices built on a proprietary bioresorbable Shape Memory Polymer (SMP) platform, including the IMPEDE Embolization Plug family (IMPEDE, IMPEDE-FX, IMPEDE-FX RapidFill) for peripheral vascular embolization and the TrelliX Embolic Coil System for neurovascular and peripheral vessel occlusion. Devices are sold to hospital interventional radiology, vascular surgery, and neurointerventional departments through direct US sales and a global distributor network spanning 40+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 1,500th patient treated milestone reached August 2022
+4 more records
Product and service4 records
1IMPEDE Embolization Plug
CategoryPeripheral Vascular Embolization Devices
Description

Shape memory polymer embolization plug with an anchor coil, used to obstruct or reduce blood flow in the peripheral vasculature; for interventional radiologists treating peripheral vessels up to 10mm in diameter.

2IMPEDE-FX Embolization Plug
CategoryPeripheral Vascular Embolization Devices
Description

Standalone shape memory polymer embolization plug used as an adjunct to the IMPEDE Embolization Plug for additional space filling in peripheral vascular embolization procedures.

3IMPEDE-FX RapidFill
CategoryPeripheral Vascular Embolization Devices
Description

Preloaded 5-device cartridge that delivers 6.25 mL of shape memory polymer in a single application for large vessel or lesion embolization; for peripheral vascular embolization. Not available for sale in the United States or Japan.

4TrelliX Embolic Coil System
CategoryNeurovascular and Peripheral Embolization Devices
Description

Composite embolic device combining a shape memory polymer over a platinum-tungsten coil for catheter delivery; self-expands to a predefined volume upon contact with blood. Indicated for neurovascular and peripheral vessel abnormalities. Not approved for sale in the United States or Japan.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-10-10
Description

Served as distribution partner driving regulatory approval process and distributing IMPEDE Embolization Plug product family (IMPEDE, IMPEDE-FX, IMPEDE-FX RapidFill) across Singapore and Malaysia as part of its pan-vascular portfolio. Also distributes in Hong Kong and Taiwan.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2023-12-11
Description

Second sublicense of Shape Memory Medical's intellectual property portfolio to another highly respected medical device manufacturer for an innovative application.

Strategic tierMajorTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2023-07-06
Description

Sublicense agreement for proprietary shape memory polymer technology for a narrow indication in a therapeutic area outside of Shape Memory Medical's cardiovascular, endovascular and neurovascular focus. Second sublicense of intellectual property portfolio.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for Japan, a Group Company of M3 Inc. listed on Tokyo Stock Exchange. Championed PMDA approval process for IMPEDE products in Japan.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

US distributor for Shape Memory Medical products.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

US distributor for Shape Memory Medical products.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Penumbra offers the Ruby Coil and POD (Penumbra Occlusion Device) systems for peripheral and neurovascular embolization. It is a direct peer in the embolization device market, with overlapping customer base in interventional radiology and neurointerventional radiology.

TypeBroad incumbent
Description

Cook Medical manufactures vascular embolization coils and the MReye Flipper and Tornado coils, plus a broad vascular intervention portfolio. It is a broad incumbent competing with Shape Memory Medical in peripheral embolization and serves the same interventional radiology departments.

TypeBroad incumbent
Description

Boston Scientific's peripheral intervention division offers embolization products including Interlock and VortX coils, plus access and closure devices. It competes with Shape Memory Medical's IMPEDE family in peripheral embolization procedures and serves the same interventional radiology customer base.

TypeBroad incumbent
Description

Stryker's Neurovascular division offers Target detachable coils and other neurovascular embolization products. It is a direct competitor in neurovascular embolization where TrelliX Embolic Coil is positioned.

TypeBroad incumbent
Description

Medtronic offers a broad embolization portfolio including Concerto detachable coils (acquired via Covidien) and peripheral embolization plugs. Several Shape Memory Medical executives, including the CCO, came from Medtronic's peripheral vascular and embolization business, and the companies compete in the same call points.

TypeEmerging player
Description

Kaneka offers the iED coil and other neurovascular embolization products in select markets, including Japan. It is an emerging player with partial overlap in the peripheral and neurovascular embolization space where Shape Memory Medical's Cosmotec partnership operates in Japan.

TypeBroad incumbent
Description

MicroVention (a Terumo subsidiary) is a leading neurovascular embolization company with hydrocoil and platinum coil systems for intracranial aneurysms and AVMs. It directly competes with TrelliX Embolic Coil in the neurovascular embolization space.

TypeBroad incumbent
Description

Cerenovus (J&J MedTech) offers neurovascular coils, including the Galaxy and Orbits, for aneurysm and AVM embolization. It is a broad incumbent in neurovascular embolization where TrelliX competes, and the CEO's prior Micrus Endovascular background is a J&J-acquired franchise.

TypeDirect peer
Description

Merit Medical offers the EmboCube and EmboZphere embolic bead products plus Bear (vascular plugs) and Bear Vac. It is a direct peer in peripheral vascular embolization and competes with the IMPEDE family for the same hospital procurement budgets.

TypeEmerging player
Description

ArtVentive Medical develops endoluminal occlusion devices (EOS) for peripheral embolization. It is a smaller emerging player with a narrower portfolio that partially overlaps with Shape Memory Medical's peripheral embolization focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds11 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Shape Memory Medical

Endovascular Embolization Devicesshapemem.com

Shape Memory Medical is a San Jose-based medical device company developing Shape Memory Polymer-based embolization devices (IMPEDE family, TrelliX coils) for interventional radiologists and vascular surgeons across 40+ countries, with active expansion into aortic indications.

What Shape Memory Medical does

Shape Memory Medical is a privately held medical device company headquartered in San Jose, California, founded in 2009 to commercialize Shape Memory Polymer (SMP) technology for endovascular embolization. The company's core platform centers on a proprietary bioresorbable polymer that expands and conforms at body temperature, enabling devices that occlude targeted vasculature while integrating embolic material into the vessel. Its commercial product family includes the IMPEDE Embolization Plug, IMPEDE-FX, IMPEDE-FX RapidFill, and the TrelliX Embolic Coil, serving interventional radiologists and vascular surgeons across peripheral and neurovascular embolization indications in more than 40 countries.

The company is expanding its clinical footprint beyond standalone embolization, with the investigational FLAGSHIP False Lumen Embolization System targeting aortic dissection and the AAA-SHAPE Pivotal Trial evaluating sac management adjunct to endovascular aneurysm repair. Regulatory positioning includes the first FDA-cleared SMP-based vascular device, EU MDR Class III certification for the IMPEDE family, PMDA approval in Japan, and recent clearances in Singapore and Malaysia. Distribution is executed through regional partners and a sublicense with a global MedTech leader, supplemented by direct commercial activity in core markets.

Commercial economics follow a B2B medical device model: the company sells Class III implantable devices to hospitals and integrated delivery networks on a per-unit basis, with ASPs typical of vascular embolization products and revenue tied directly to procedure volumes. The company has cumulatively treated more than 3,000 patients as of March 2025, with total disclosed equity funding exceeding $50M, including a $38M Series C led by Earlybird Venture Capital in March 2024 and a $17M follow-on in April 2025.

Shape Memory Medical firmographics

Firmographics
Name
Shape Memory Medical
Legal name
Shape Memory Medical, Inc.
Website
https://shapemem.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
Shape Memory Medical is a San Jose-based medical device company developing Shape Memory Polymer-based embolization devices (IMPEDE family, TrelliX coils) for interventional radiologists and vascular surgeons across 40+ countries, with active expansion into aortic indications.
Ownership category
akta.pro rank

Shape Memory Medical industry classification

Industry
Product category
Endovascular Embolization Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)
akta.pro secondary industries
Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy) (HLAHAFAE), Stroke & Vascular Neurology (HLAKAIAG)

Keywords

  • Shape memory polymer devices
  • Vascular embolization plugs
  • Neurovascular embolic coils
  • Bioresorbable endovascular devices
  • Peripheral embolization products

Where Shape Memory Medical is headquartered

Location

Headquarters

HQ city
Santa Clara
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Shape Memory Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Medical Device Sales: Sale of proprietary shape memory polymer embolization devices to hospitals and healthcare facilities. Revenue generated from one-time device purchases by interventional radiology and vascular surgery departments. Products include IMPEDE Embolization Plug, IMPEDE-FX Embolization Plug, IMPEDE-FX RapidFill, and TrelliX Embolic Coil System.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Shape Memory Medical product offering

Product offering

Core offering

Shape Memory Medical develops and commercializes implantable endovascular embolization devices built on a proprietary bioresorbable Shape Memory Polymer (SMP) platform, including the IMPEDE Embolization Plug family (IMPEDE, IMPEDE-FX, IMPEDE-FX RapidFill) for peripheral vascular embolization and the TrelliX Embolic Coil System for neurovascular and peripheral vessel occlusion. Devices are sold to hospital interventional radiology, vascular surgery, and neurointerventional departments through direct US sales and a global distributor network spanning 40+ countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Impede: IMPEDE Embolization Plug family of embolic plugs for peripheral vascular embolization procedures using shape memory polymer technology.
  • Impede-FX
  • Impede-FX RapidFill
  • TrelliX
  • AAA-SHAPE
  • FLAGSHIP
  • EMBO-PMS

Products and services

  • IMPEDE Embolization Plug Shape memory polymer embolization plug with an anchor coil, used to obstruct or reduce blood flow in the peripheral vasculature; for interventional radiologists treating peripheral vessels up to 10mm in diameter.
  • IMPEDE-FX Embolization Plug Standalone shape memory polymer embolization plug used as an adjunct to the IMPEDE Embolization Plug for additional space filling in peripheral vascular embolization procedures.
  • IMPEDE-FX RapidFill Preloaded 5-device cartridge that delivers 6.25 mL of shape memory polymer in a single application for large vessel or lesion embolization; for peripheral vascular embolization. Not available for sale in the United States or Japan.
  • TrelliX Embolic Coil System Composite embolic device combining a shape memory polymer over a platinum-tungsten coil for catheter delivery; self-expands to a predefined volume upon contact with blood. Indicated for neurovascular and peripheral vessel abnormalities. Not approved for sale in the United States or Japan.

Quantifiable outcome

  • 1,500th patient treated milestone reached August 2022
  • +4 more outcomes

Companies that use Shape Memory Medical

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Shape Memory Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Shape Memory Medical partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered major and core.

  • Getz HealthcaremajorChannel Partner/ Reseller/ Distributor · 10 October 2025Served as distribution partner driving regulatory approval process and distributing IMPEDE Embolization Plug product family (IMPEDE, IMPEDE-FX, IMPEDE-FX RapidFill) across Singapore and Malaysia as part of its pan-vascular portfolio. Also distributes in Hong Kong and Taiwan.
  • Major Medical Device ManufacturercoreOEM/ Whitelabel/ Licensing Partner · 11 December 2023Second sublicense of Shape Memory Medical's intellectual property portfolio to another highly respected medical device manufacturer for an innovative application.
  • Global MedTech Market LeadermajorOEM/ Whitelabel/ Licensing Partner · 6 July 2023Sublicense agreement for proprietary shape memory polymer technology for a narrow indication in a therapeutic area outside of Shape Memory Medical's cardiovascular, endovascular and neurovascular focus. Second sublicense of intellectual property portfolio.
  • COSMOTEC CO, LTDmajorChannel Partner/ Reseller/ DistributorDistribution partner for Japan, a Group Company of M3 Inc. listed on Tokyo Stock Exchange. Championed PMDA approval process for IMPEDE products in Japan.
  • Appleton Medical Service Inc.coreChannel Partner/ Reseller/ DistributorUS distributor for Shape Memory Medical products.
  • State Of The Art Medical Products (SOTA)coreChannel Partner/ Reseller/ DistributorUS distributor for Shape Memory Medical products.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Shape Memory Medical competitors and assessment

Company assessment

Direct peers

  • Penumbra: Penumbra offers the Ruby Coil and POD (Penumbra Occlusion Device) systems for peripheral and neurovascular embolization. It is a direct peer in the embolization device market, with overlapping customer base in interventional radiology and neurointerventional radiology.
  • Merit Medical Systems: Merit Medical offers the EmboCube and EmboZphere embolic bead products plus Bear (vascular plugs) and Bear Vac. It is a direct peer in peripheral vascular embolization and competes with the IMPEDE family for the same hospital procurement budgets.

Broad incumbents

  • Cook Medical: Cook Medical manufactures vascular embolization coils and the MReye Flipper and Tornado coils, plus a broad vascular intervention portfolio. It is a broad incumbent competing with Shape Memory Medical in peripheral embolization and serves the same interventional radiology departments.
  • Boston Scientific: Boston Scientific's peripheral intervention division offers embolization products including Interlock and VortX coils, plus access and closure devices. It competes with Shape Memory Medical's IMPEDE family in peripheral embolization procedures and serves the same interventional radiology customer base.
  • Stryker: Stryker's Neurovascular division offers Target detachable coils and other neurovascular embolization products. It is a direct competitor in neurovascular embolization where TrelliX Embolic Coil is positioned.
  • Medtronic: Medtronic offers a broad embolization portfolio including Concerto detachable coils (acquired via Covidien) and peripheral embolization plugs. Several Shape Memory Medical executives, including the CCO, came from Medtronic's peripheral vascular and embolization business, and the companies compete in the same call points.
  • Terumo (MicroVention): MicroVention (a Terumo subsidiary) is a leading neurovascular embolization company with hydrocoil and platinum coil systems for intracranial aneurysms and AVMs. It directly competes with TrelliX Embolic Coil in the neurovascular embolization space.
  • Johnson & Johnson (Cerenovus): Cerenovus (J&J MedTech) offers neurovascular coils, including the Galaxy and Orbits, for aneurysm and AVM embolization. It is a broad incumbent in neurovascular embolization where TrelliX competes, and the CEO's prior Micrus Endovascular background is a J&J-acquired franchise.

Emerging players

  • Kaneka: Kaneka offers the iED coil and other neurovascular embolization products in select markets, including Japan. It is an emerging player with partial overlap in the peripheral and neurovascular embolization space where Shape Memory Medical's Cosmotec partnership operates in Japan.
  • ArtVentive Medical: ArtVentive Medical develops endoluminal occlusion devices (EOS) for peripheral embolization. It is a smaller emerging player with a narrower portfolio that partially overlaps with Shape Memory Medical's peripheral embolization focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Shape Memory Medical social profiles

Digital presence

Shape Memory Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Shape Memory Medical leadership team

Management profile

Number of profiles

Profiles7 records

Shape Memory Medical funding detail

Funding detail

Funding overview

Funding rounds11 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Shape Memory Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Shape Memory Medical

What does Shape Memory Medical do?

Shape Memory Medical develops and commercializes implantable endovascular embolization devices built on a proprietary bioresorbable Shape Memory Polymer (SMP) platform, including the IMPEDE Embolization Plug family (IMPEDE, IMPEDE-FX, IMPEDE-FX RapidFill) for peripheral vascular embolization and the TrelliX Embolic Coil System for neurovascular and peripheral vessel occlusion. Devices are sold to hospital interventional radiology, vascular surgery, and neurointerventional departments through direct US sales and a global distributor network spanning 40+ countries.

Is Shape Memory Medical a public or private company?

Shape Memory Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Shape Memory Medical founded?

Shape Memory Medical was founded in 2009. It employs 11 to 50 people.

Where is Shape Memory Medical based?

Shape Memory Medical is headquartered in Santa Clara, United States, in the North America region.

How does Shape Memory Medical make money?

One revenue line is on record: medical Device Sales.

Who are Shape Memory Medical's main competitors?

Direct peers on record are Penumbra and Merit Medical Systems. Broad incumbents are Cook Medical, Boston Scientific, Stryker, Medtronic, Terumo (MicroVention) and Johnson & Johnson (Cerenovus). Emerging players are Kaneka and ArtVentive Medical.

Does Shape Memory Medical have an API?

No public API is recorded for Shape Memory Medical.

What industry is Shape Memory Medical in?

Shape Memory Medical's product category is Endovascular Embolization Devices. Its primary akta.pro industry code is HLAHAFAJ, Thrombectomy, Embolic Protection & Stroke Intervention Devices, with a secondary code of HLAHAFAE, Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageShape Memory Medical Receives ANVISA Market Authorization for IMPEDE Embolization Plug Family in BrazilShape Memory Medical received ANVISA authorization for its IMPEDE Embolization Plug, IMPEDE-FX Embolization Plug, and IMPEDE-FX RapidFill in Brazil. The approval supports the company's expansion in the Latin American endovascular market, which is projected to grow over 10% annually.Pulse 2.0Shape Memory Medical Raises $10 Million Led By August Global Partners To Advance Aortic Clinical TrialsShape Memory Medical closed a $10 million convertible note financing led by August Global Partners, with Taiwania Capital joining as a new investor, alongside backers including HBM Healthcare Investments, Earlybird Venture Capital and WexMed II. The capital funds patient follow-up in its AAA-SHAPE Pivotal Trial, which enrolled recently and will follow patients for five years, and the FLAGSHIP feasibility study, running two years.GsmedtechShape Memory Medical raises $10M to advance aortic clinical trialsShape Memory Medical raised $10M in convertible note financing led by August Global Partners. The funds will support patient follow-up and data collection in its AAA-SHAPE Pivotal Trial and advance its FLAGSHIP feasibility study. Enrollment in AAA-SHAPE completed with 180 patients across 48 sites, with five-year follow-up planned.DealStreetAsiaAugust Global Partners leads $10m round for US medical device companyAugust Global Partners led a $10-million convertible note financing for Shape Memory Medical, a California-based medical device company. The funding will support its AAA-SHAPE pivotal trial and FLAGSHIP feasibility study for aortic disease treatments. The company's products have regulatory approvals in over 40 countries and have been used in more than 3,500 patients worldwide.Medical BuyerShape Memory Medical closes USD 10M convertible note financingShape Memory Medical Inc. has closed a $10 million convertible note financing led by August Global Partners and joined by Taiwania Capital to fund the clinical development of its aortic portfolio. The capital will support patient follow-up for the completed AAA-SHAPE Pivotal Trial and the advancement of the FLAGSHIP feasibility trial for aortic dissection treatment.Hospital ManagementShape Memory Medical secures $10m to advance aortic clinical trialsShape Memory Medical raised $10m in convertible note financing led by August Global Partners, with Taiwania Capital and HEAL Venture Lab joining, to fund patient follow-up and data collection in its aortic trials. The company's AAA-SHAPE Pivotal Trial enrolled 180 patients at 48 centres and FLAGSHIP is enrolling for aortic dissection. Products have regulatory approval in over 40 countries and been used in more than 3,500 patients.Medical Device NetworkShape Memory Medical secures $10m to advance aortic clinical trialsShape Memory Medical has secured $10 million in convertible note financing led by August Global Partners to support the clinical development of its aortic portfolio. The funds will facilitate patient follow-up and data collection for the AAA-SHAPE Pivotal Trial, which recently completed enrollment, as well as the advancement of the FLAGSHIP feasibility study. This investment positions the company to generate critical clinical evidence needed for broader adoption of its shape memory polymer technology in treating aortic aneurysms and dissections.YahooShape Memory Medical secures $10m to advance aortic clinical trialsShape Memory Medical raised $10m in convertible note financing led by August Global Partners to advance aortic clinical trials. The funding supports the AAA-SHAPE Pivotal Trial and FLAGSHIP feasibility study, with enrolment completed in AAA-SHAPE. The company's shape memory polymer platform has regulatory approvals in over 40 countries and has been used in more than 3,500 patients.citybizShape Memory Medical Raises $10 Million to Advance Aortic Clinical ProgramsShape Memory Medical raised $10 million in convertible note financing led by August Global Partners, with Taiwania Capital joining. The capital will advance clinical programs, including the fully enrolled AAA-SHAPE Pivotal Trial and the FLAGSHIP first-in-human study for aortic dissection. The company plans to use the funds for continued development of its aortic portfolio.FinSMEsShape Memory Medical Raises $10M in Convertible Note FinancingShape Memory Medical raised $10M in convertible note financing led by August Global Partners with Taiwania Capital. The funds will support clinical development of its aortic portfolio, including the AAA-SHAPE Pivotal Trial and FLAGSHIP feasibility trial. The company holds CE Mark approvals and has been used in over 3,500 patients.